degeneration should be well understood in parallel to the development of molecular medicine. The prolongation of human life results in formation of degeneration of intervertebral disc and disc herniation with age, and therefore, research into new treatment choices is necessary.
The extracellular matrix structure of intervertebral discs consists of collagens, proteoglycans and non-collagen proteins. The biological basis of healthy disc tissue is based on disc cells functioning properly. The intervertebral disc is a tissue that is poor in term of cells. Cells of the disc consist of fibrocytes and chondrocytes. Cells occupy 1-5% of disc █ 
INTRODUCTION
Intervertebral discs start to degenerate from the moment a human begins to stand and walk (3, 8) . Degeneration of discs is not a result solely of aging and misuse of the lower back. It is known that many extrinsic, intrinsic and genetic factors play a role in the degeneration of discs (15) . Generally, the effect of extrinsic factors such as trauma, heavy load lifting and working conditions on degeneration has been addressed (14) . Systemic diseases (14) , smoking (5) , as well as genetic factors, can also degenerate the disc (3, 12) . For this reason, the structure of intervertebral discs and pathophysiology of volume. The number of cells diminishes rapidly from the cartilage end plates towards the nucleus. End plate cells are typical chondrocytes (10, 19) .
Matrix metalloproteinase (MMP) is released in inactive proenzyme form in the extracellular matrix. It is considered to play a role in disc degeneration by degrading collagen and proteoglycans found in the matrix (1, 13) . The role of biochemical mediators seen in the degeneration of discs has not attracted much attention until recently. In recent years, metalloproteinases have come to the forefront among related proteinases after the existence of proteolytic enzymes in the disc structure was discovered. Many studies have concluded that expressions of enzymes that degrade the matrix in intervertebral disc degeneration increase. It was shown in the literature that some alleles of the MMP-3 gene are associated with disc degeneration of elderly Japanese patients (2).
MMP-11, from the metalloproteinase family, is a proteinase weighing 47 kDA. It is differentiated from other MMP members in terms of both enzymatic activity and activation. It has an extremely wide substrate range; it has features of splitting the non-helical region of proteoglycan, laminin, fibronectin casein and collagen (7) . It was shown in the literature that other stromelysin group enzymes have increased expression in osteoarthritis patients and also MMP-11 enzyme activity increased in the late stage of the same patients (6) . There is no data in the literature regarding a role for it in disc degeneration. However, many studies have shown other MMP group enzymes playing such a role (11) .
█ MATERIAl and METhODS
Fifty-six consecutive patients with herniated lumbar disc who were operated on between September 2008 and December 2009 were analyzed prospectively. The study had the approval of an ethics committee. Histories and complaints of the cases were obtained from their records. Neuroradiological assessment of the cases was performed with magnetic resonance imaging (MRI) work-up. Schneiderman Disc Degeneration classification was applied in T2-weighted MRI scans during the neuroradiological assessment, as described previously (22) (Table I) . Possible correlations between variables such as MMP-11 staining score, Schneiderman score, surgery level, gender and age group were investigated.
Surgical and Histopathological Classifications
Surgical findings of the cases were determined by examination of the operation notes of the cases. Standard microscopic hemipartial laminectomy, foraminotomy and discectomy were applied in all cases. Samples obtained from the herniated and degenerated disc material during the surgery were examined histopathologically. Specimens were kept in 10% formalin at room temperature for 24 hours and then they were embedded into paraffin. Four mm histological sections were prepared from paraffin blocks on lams coated with 3-amino propyl-triethoxysilane (A-3648, Sigma Aldrich Inc., USA). Degenerated intervertebral disc tissue specimens underwent immunohistochemical processes and were stained with ready-to-use monoclonal antibodies. The monoclonal antibody used, MMP-11 mouse monoclonal antibody, was provided by Santa Cruz Inc. (SC MS-1035-R7).
Prior to immunohistochemical analysis, control tissues envisaged for each antibody were stained. After positive staining was determined, a test group was stained and evaluated.
Immunohistochemical density evaluation was performed by the neuropathologist according to a semi-quantitative analysis system. Classifications were no staining (-), focal staining (staining below 10%) (+), moderate staining (staining between 10-50%) (++), and prevalent staining (staining above 50%) (+++) ( Table II) .
█ RESUlTS
Age and gender data, staining score and MRI score belonging to operations of 56 cases that were the subject of the research and these operation levels were examined. After descriptive statistics of variables were examined with statistical analysis, Chi-Square analysis was applied. Analysis was conducted using SPSS 16.0 (SPSS Inc., Chicago, IL, USA) software and an error margin of 5% was accepted.
Fifty percent of the cases consisted of women and 50% were men. Ages of cases ranged between 13 and 77 years. Average age was 47. Cases were divided into two groups as above 50 years old and below 50 years old. There were 30 cases in the ≤50 years group and 26 cases above 50 years old.
Staining was not observed in 57.1% of cases (32 patients), staining less than 10% was seen in 28.6% (16 patients), 10-50% staining in 10.7% (6 patients), and more than 50% staining was found in 3.6% (2 patients) ( Figure 1A-D) .
Grade I degeneration was found in 3.6% of cases (2 patients), Grade II in 62.5% (35 patients) and Grade III in 33.9% (19 patients) in evaluation of MRI findings (Figure 2A-D) .
Operations were performed at L3-L4 level in 10.7% of cases (6 patients), at L4-L5 level in 58.9% (33 patients) and L5-S1 level in 30.4% (17 patients).
While the MMP-11 staining in the group 50 years and younger was 56%, this rate was 26.9% in the group above 50 years of age. Statistical significance was determined between staining degrees of patients aged ≤50 and staining degrees of patients aged >50. This implies that the MMP-11 enzyme may play a role in disc degeneration in patient aged 50 years and younger. MMP-11 positivity was seen in 42.3%, MMP-11 negativity in 57.1% in this study. 
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proteoglycans found in the structure of a disc is MMP (21) .
There are many studies concluding that the stromelysin group of enzymes plays a role in disc degeneration.
In a study conducted by Barksby et al., MMP-10 expression was isolated from hip cartilage chondrocytes in patients with osteoarthritis. The same study showed that MMP-10 enzyme activated pro MMP-1, 8, 11, 13 (4).
In a study by Richardson et al., the MMP-10 enzyme's role in disc degeneration was investigated. It was found that MMP-10 enzyme expression is significantly high in degenerated disc specimens. Substantially dense staining was seen in immunohistochemical staining specimens (21) . This increase in MMP-10 enzyme leads us to suggest that they have a role in disc degeneration together with MMP-3 and MMP-11 enzymes with the same substrate properties.
As noted previously, disc degeneration starts in the early years of life. Epidemiological studies show that inheritance is the most important factor in disc degeneration. In a study conducted by Dong et al., it was stated that those who develop Risk factors in intervertebral disc herniation have been determined as young-middle age, male gender, familial tendency, environmental factors, trauma and smoking. In a broad study conducted, the female/male ratio was 1/1.6. The percentages were equal in this study. Degeneration in discs below L4 level develops more quickly due to bio-mechanics and the physical weight of the spine, and this allows the formation of disc hernia (4). This study is in accord with that statement.
Miller stated that intervertebral discs undergo one of the most dramatic changes among connective tissues in the human body (17) . There are many studies showing that degeneration increases and neuroradiological findings deteriorate with aging (16). In our study, it was seen that the degeneration degree increases as age increases when degeneration findings were evaluated by age and MRI scans.
Many studies show that expressions of enzymes degrading the matrix increase in intervertebral disc degeneration (21) . These are MMP and ADAMS TS enzyme families. The most important enzyme group responsible for degradation of 
disc degeneration in early years have more genetic tendency, and it was noted that MMP-2 1306 C/T polymorphism may be a genetic risk factor associated with a tendency for lumbar disc disease in young adults (9) .
In the current study, the role of MMP-11, which is another enzyme of stromelysin group, was investigated in disc degeneration by immunohistochemical staining of removed disc materials. There is no study related to this in the literature. However, an expression increase was shown in many diseases (7) . In our study, while MMP-11 positivity was seen in 42.3% of disc materials taken during the operation, MMP-11 negativity was seen in 57.1%. However, this rate was low when it was considered that other stromelysins with similar substrate property have important roles in disc degeneration. Although there is no data related with MMP11 in the literature, it was thought that MMP-11 may have a role in disc degeneration.
Lumbar disc herniation is more frequently seen in male and young-middle aged patients (9). The age limit was determined as 50 years old in our study by taking this into consideration and we divided the cases into two groups. In evaluations between the two groups, we found a statistically significant difference between MMP-11 staining degrees. This difference caused us to think that the MMP-11 enzyme may have a role in patients with disc degeneration in young-middle age. Prolongation of human life and ineffective treatment methods indicate that proposed new treatment choices that will prevent degeneration of intervertebral discs should be on the agenda. MMP continues to be important as a very strong mediator in the degeneration of intervertebral discs. Studies conducted in recent years focus on agents inhibiting synthesis and activity of MMP (3, 12, 18) . Improvements in this regard are still in the experimental stage. Adverse effects of the substances investigated have meant they could not be used in humans until now. However, it may be possible to develop more specific therapeutic agents with a better understanding of macro-molecules of intervertebral discs, the effect of degeneration on pathogenesis and the regulation mechanism of matrix molecules by benefiting from immunohistochemistry and modern techniques.
In conclusion, it was shown in this study that MMP11 may play a role in the pathogenesis of intervertebral disc disease. However, disc degeneration is not a factor by itself. It is considered that it may be a risk factor genetically in youngmiddle aged patients.
This study showed the presence of MMP-11 enzyme in disc tissue with immunohistochemical staining in a small series. Wider series of immunohistochemical staining for MMP-11 and other MMPs, and simultaneous genetic studies, will illuminate the role of MMPs in the pathogenesis of disc degeneration and thus make it possible to develop more specific agents.
